Here are relevant reports on : artificial-intelligence-ai-in-drug-discovery-market
-
Germany Artificial Intelligence in Manufacturing Market by Processor (MPUS, GPUs, FPGA, ASICs), Software (On-premises, Cloud), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision, Generative Al), Application - Forecast to 2030
The Germany artificial intelligence in manufacturing market is projected to grow from USD 2.14 billion in 2026 and to reach USD 10.50 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 35.8% during the forecast period. Key companies providing innovative, data-driven solutions in this market include Siemens (Germany), ABB (Switzerland), and IBM (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Tourism Market by Solution (Virtual Assistant & Chatbots, Pricing & Revenue Management, Booking Management System), End Users (Maritime Travel, Aviation, Cruise Line Operators, Resorts & Theme Parks) - Global Forecast to 2030
The AI in tourism market is projected to reach USD 13.38 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 28.7% during the forecast period. The major vendors covered in the AI in tourism market are Snowflake (US), IBM (US), NVIDIA (US), Microsoft (US), AWS (US), Salesforce (US), Huawei (China), Appier (Taiwan), Sabre Corporation (US), SAS Institute (US), [24]7.ai (US), Virtusa Corporation (US), Travelport (UK), Amadeus (Spain), Devon Software (Poland) , Artisoft (US), Jio Haptik Technologies Limited (India), SHR Group (US), Duve (US), Nescient (US), Persado (US), Canary Technologies (US), Mize (US), FLYR (US), Geovana (US), Layla AI (Germany). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the AI in tourism market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030
The global cell-based assays market, valued at US$17.36B in 2024, is forecasted to grow at a 9.1% CAGR, reaching US$18.134B by 2025 and US$25.77B by 2030. Growth in this market is primarily driven by the increasing demand for drug discovery and development, the increasing preference for cell-based assays in drug discovery, and the rising prevalence of cancer.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Microscopy Market by Product [Optical Microscope: Stereo, Digital; Electron microscope: SEM, TEM, AFM, STM], Application (Pharma Mfg, Pathology, Drug Discovery, Toxicology), End User (Pharma-biopharma, Academia, Semiconductor) — Forecast to 2031
The Asia-Pacific microscopy market is projected to reach USD 2.56 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031
The global wearables in pharma & biotech market is projected to reach USD 9.97 billion by 2031, growing at a CAGR of 20.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
North America Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The North America next-generation sequencing Market, valued at US$5.83 billion in 2024, stood at US$6.15 billion in 2025 and is projected to advance at a resilient CAGR of 13.6% from 2025 to 2030, culminating in a forecasted valuation of US$11.63 billion by the end of the period. The expansion of the North American NGS market is driven by increasing adoption of sequencing in oncology and precision medicine, the growing prevalence of cancer and other chronic diseases, and ongoing advances that lower sequencing costs while enhancing throughput and data quality.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
China Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The China Next-Generation Sequencing market, valued at USD 1.23 billion in 2025, stood at USD 1.35 billion in 2026 and is projected to advance at a resilient CAGR of 16.0% from 2026 to 2031, culminating in a forecasted valuation of USD 2.84 billion by the end of the period. Next-generation sequencing refers to advanced DNA and RNA sequencing technologies that enable rapid, high-throughput analysis of genetic material.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031
The global digital twins in healthcare market is projected to reach USD 101.19 billion by 2031, growing at a CAGR of 68.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030
The Asia Pacific Next-generation Sequencing market, valued at US$3.11 billion in 2024, stood at US$3.40 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.38 billion by the end of the period. Market growth is supported by substantial public and private investment in genomics, including national genome and precision medicine initiatives in China, Japan, India, South Korea, Singapore, and Australia, alongside ongoing advances that are lowering sequencing costs and improving throughput and data analytics.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
